SharePoint
A- A A+
Home > Patients and Visitors > Health Library




















VRD Regimen (Bortezomib-Lenalidomide-Dexamethasone)

VRD regimen is used to treat multiple myeloma. It consists of an injection Velcade® (Bortezomib), an doral cancer drug Revlimid® (Lenalidomide) and an oral/injection steroid Dexamethasone. ​

[Please download the PDF file if you are unable to view the image below.]

 
2020/10/27
2020/11/04
Last Updated on